Cardiovascular diseases

Photo

News • Synthetic nucleic acid

New approach could help weak hearts

Heart failure with preserved ejection fraction was previously considered largely untreatable. A research team at the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) led by Professor Michael Gotthardt has now succeeded for the first time in improving cardiac function with the help of a synthetic nucleic acid, as the researchers report in the journal Science…

Photo

News • Coronary microcirculation

New measurements improve diagnosis of ‘woman’s heart’

Researchers at the Catharina Heart and Vascular Center, together with Eindhoven University of Technology, have developed a new measurement method to analyze the smallest capillaries of the heart by measuring blood flow and resistance. The new method to assess coronary microcirculation allows cardiologists to make a clearer diagnosis. Until recently, the tests used for this purpose were not…

Photo

News • Online platform for professionals

Cardiology webinars take a glimpse into the future of the field

In continuation of their healthcare webinar series, Canon Medical announces the Online Cardiology Days. From Oct 26 to Nov 4, world-renowned cardiology experts take a deep-dive into professional education and explore state-of-the-art imaging and clinical management insights during a series of interactive lectures, practical teaching sessions and real life clinical case discussions.

Photo

News • Cardiology research

Transcatheter aortic valve replacement: new insights on life expectancy

Researchers at Karolinska Institutet have examined long-term outcomes in patients who received pacemaker implantations after transcatheter aortic valve replacement (TAVR) through their groin. The result showed no significant difference in mortality for the patients with pacemakers compared to those without. The study is published in the journal JACC: Cardiovascular Interventions.

Photo

News • Medication combination

'4-in-1' blood pressure pill shows great promise

The first large-scale, long-term trial of a new strategy using combinations of very low-doses in one capsule, has demonstrated significantly improved control of high blood pressure - the leading cause of heart attack and stroke. This first large-scale, randomised controlled clinical trial of starting this novel combination blood pressure medication brought blood pressure under control in 80…

597 show more articles
Subscribe to Newsletter